| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding | |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | Entrez:924 MIM:186820 HGNC:HGNC:1695 Ensembl:ENSG00000173762 AllianceGenome:HGNC:1695 | |
| Description | CD7 molecule | |||||
| GTO ID | GTC0914 |
| Trial ID | ChiCTR2100042807 |
| Disease | Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A single-center, open, non-randomized, single-arm clinical trial of autologous CD7-CAR T cells in the treatment of refractory/relapsed CD7-positive lymphoma |
| Year | 2021 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Cohort 1 | |||||||||
|
|||||||||